AUKERA THERAPEUTICS
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.
AUKERA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Total Employee:
1+
Status:
Active
Total Funding:
650 K CHF
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Cellinta
Cellinta Limited is a biotechnology company that develops cancer-identifying technology with help of gene therapy for ant-cancer payloads.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Oncos Therapeutics
Oncos Therapeutics is a biotech company developing cancer therapies based on its next generation oncolytic viruses.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Grant - Aukera Therapeutics
BaseLaunch
BaseLaunch investment in Pre Seed Round - Aukera Therapeutics
More informations about "Aukera Therapeutics"
Aukera, Inc. – Safe and Effective Delivery of …
Safe and Effective Delivery of Therapeutics Using Nature’s Design. About Us Technology. Our Solution Aukera's Vault Nanocapsule platform. ... Aukera, Inc. is a private biotechnology company that has developed a novel vault protein …See details»
Aukera Therapeutics
Aukera Therapeutics is a preclinical-stage biotech spin-off from the University of Basel, …See details»
Aukera Therapeutics - Crunchbase Company Profile
Organization. Aukera Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Aukera …See details»
Aukera Therapeutics Company Profile 2024: Valuation, Funding ...
Aukera Therapeutics General Information Description. Developer of a pharmaceutical drug …See details»
Aukera Therapeutics - Crunchbase Company Profile & Funding
Aukera Therapeutics is developing a novel protein therapy. Aukera Therapeutics is developing …See details»
Aukera Therapeutics - LinkedIn
Aukera Therapeutics is a preclinical-stage biotech spin-off from the University of Basel, …See details»
Aukera Therapeutics GmbH - Swiss Biotech
Aukera builds a discovery engine that allows designing new classes of drugs to selectively …See details»
Venture Kick support for Biozentrum spin-off Aukera Therapeutics
Oct 19, 2022 The start-up Aukera Therapeutics, founded at the Biozentrum of the University …See details»
Fresh funds to unleash the therapeutic potential of mTOR inhibition
Dec 10, 2022 Founded in 2021 by Stefan Imseng (CEO) and Dritan Liko (Head of Biology), …See details»
CHF 40,000 for Novel mTOR inhibitors to treat rare …
Mar 30, 2022 Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.CEO Dr. Stefan Imseng, Head of Biology Dr. Dritan Liko, Medicinal Chemist Dr. Werner Neidhart, and Scientific advisors from the …See details»
Aukera Therapeutics joins BaseLaunch Portfolio
Basel, Switzerland., 15 February 2022 — Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel, founded by Stefan Imseng and Dritan Liko.The company emerged from the laboratories of Michael Hall – who …See details»
Aukera Therapeutics qualifies for BaseLaunch funding program
Feb 21, 2022 The spin-off Aukera Therapeutics, which was founded at the Biozentrum last …See details»
Aukera Therapeutics at the Swiss Biotech Day
Aukera Therapeutics builds a discovery engine that allows designing new classes of drugs to …See details»
Aukera Therapeutics wins CHF 150,000 to unleash the therapeutic ...
Nov 10, 2022 Aukera Therapeutics emerged from the laboratories of Prof. Michael Hall – who …See details»
Aukera Therapeutics, Inc. - VentureRadar
Aukera Therapeutics is developing a novel protein therapy, to treat ALS (also known as Lou …See details»
Aukera Therapeutics qualifies for BaseLaunch funding program
Feb 18, 2022 The spin-off Aukera Therapeutics, which was founded at the Biozentrum last …See details»
Aukera Therapeutics (Drug Discovery) - PitchBook
Jun 11, 2010 Aukera Therapeutics (Drug Discovery) General Information Description. …See details»
Aukera Therapeutics - Funding, Financials, Valuation & Investors
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients …See details»
Aukera Therapeutics GmbH - Venture Kick
Dec 10, 2022 Aukera Therapeutics GmbH: Aukera Therapeutics is a spin-off from the …See details»
Aukera Therapeutics - Contacts, Employees, Board Members
Organization. Aukera Therapeutics . Connect to CRM . Save . Summary. Financials. People. …See details»